FKB01MD

TGBA01AD

Clinical data
Synonyms	FKB01MD
Routes of administration	Oral
Pharmacokinetic data
Bioavailability	17%
Elimination half-life	4 hours

TGBA01AD (also known as FKB01MD) is a serotonin reuptake inhibitor, 5-HT_1A and 5-HT_1D receptor agonist, and 5-HT₂ receptor antagonist which is under development by Fabre-Kramer for the treatment of major depressive disorder. It has been in phase II clinical trials since 2009, and as of January 2016, remains in this phase of development.

...
Wikipedia